Literature DB >> 1883740

Immunocytochemical investigation of the tissue of origin of two lung cancer cell lines.

M R Daniel1, H E Burnett.   

Abstract

The constitutive cell types of the two lung cancer cell lines CaLu1 and CaLu3 have been investigated by immunocytochemical staining with markers for cytokeratins, vimentin, carcinoembryonic antigen and the epithelial cell epitope recognized by the monoclonal antibody Ber-EP4. The cells of both lines reacted with vimentin, with CAM 5.2, which is a marker for cytokeratins 8, 18 and 19, and with a specific marker for cytokeratin 19. CaLu3 cultures showed patchy staining, and CaLu1 none, when treated with a monoclonal antibody reactive with cytokeratins 13, 14 and 17. CaLu3 cells all reacted strongly with Ber-EP4 and the antibody to carcinoembryonic antigen, whereas CaLu1 gave a negative reaction with both these reagents. These results indicate that the CaLu3 line has retained antigens characteristic of some bronchial adenocarcinomata, and that the CaLu1 line was derived from a mesothelioma rather than a pleural metastasis of a squamous carcinoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883740      PMCID: PMC2001968     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  16 in total

1.  Dome formation of keratin-containing agranular cells from rat anterior pituitary gland in vitro.

Authors:  T Shimada; F Nakamura
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

2.  Characteristics of normal and malignant human mesothelial cells studied in vitro.

Authors:  C W Castor; B Naylor
Journal:  Lab Invest       Date:  1969-05       Impact factor: 5.662

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Human lung tumours may coexpress different classes of intermediate filaments.

Authors:  K C Gatter; M S Dunnill; G N Van Muijen; D Y Mason
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

5.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

Authors:  U Latza; G Niedobitek; R Schwarting; H Nekarda; H Stein
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

6.  Clinicopathological study on the relationship between serum-CEA and tissue-CEA of resected lung cancer cases.

Authors:  A Okamura; J Ohkawa; H Fujisawa; T Sashikata
Journal:  Acta Pathol Jpn       Date:  1984-11

7.  Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.

Authors:  J L Broers; F C Ramaekers; M K Rot; T Oostendorp; A Huysmans; G N van Muijen; S S Wagenaar; G P Vooijs
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

8.  Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

Authors:  A K Ghosh; K C Gatter; M S Dunnill; D Y Mason
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

9.  Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines.

Authors:  G A Blobel; R Moll; W W Franke; I Vogt-Moykopf
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

10.  A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins.

Authors:  J Bartek; E M Durban; R C Hallowes; J Taylor-Papadimitriou
Journal:  J Cell Sci       Date:  1985-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.